Predict your next investment

RETAIL (NON-INTERNET/MOBILE) | Grocery
shuyupingmin.com

See what CB Insights has to offer

Founded Year

1999

Stage

IPO | IPO

Total Raised

$70.77M

Date of IPO

7/6/2021

About ShuYu Civilian Pharmacy

ShuYu Civilian Pharmacy (301017.SZ) is an operator of a pharmacy chain. The company operates a pharmacy franchise that provides prescription drugs (Rx), over the counter (OTC) drugs, traditional Chinese medicines prepared in ready-to-use forms, chemico-pharmaceutical preparations, antibiotics preparations, and Chinese proprietary medicines which are also available for purchase via its official e-commerce site. The platform also includes digital healthcare counseling.

ShuYu Civilian Pharmacy Headquarter Location

56 Shanda North Road Licheng District

Jinan, Shandong, 250032,

China

86 531 66898931

Latest ShuYu Civilian Pharmacy News

AliHealth Expands Offline With USD120 Million Pharmacy Deal

Sep 11, 2019

(Yicai Global) Aug. 20 -- The health spin-off of leading Chinese e-commerce player Alibaba Group Holding will take its business further into the offline world by taking a stake in one of the country's largest regional pharmacy chains. Alibaba Health Information Technology will pay some CNY826 million (USD120 million) for a 25 percent share of Yishu Chainstore Pharmaceutical, the biggest drugstore operator in the country's southwestern Guizhou province, according to a statement from the Hangzhou-based company. The two parties will "explore and expand new retail models for pharmacies in the regions where the target company has an advantage," the statement said, adding that they will "provide consumers with greater, broader and more convenient pharmaceutical services." The move marks the second such deal for AliHealth since Alibaba merged it with Tmall Pharmacy in late May in a USD1.4 billion deal. The firm invested some CNY454 million in ShuYu Civilian Pharmacy the month after, demonstrating the company's intention to gain a firm foothold in China's fast-growing pharmaceutical retail sector. China's private healthcare sector has become a key battleground for China's technology conglomerates. Alibaba Health faces stiff competition against other major players including Tencent Holdings' WeDoctor and Ping An Healthcare in its efforts to expand market share. Domestic expenditure in the sector is expected to hit USD1 trillion by 2020 from USD357 billion in 2011, states a report from McKinsey. The country's increasingly aging population could present new growth opportunities for pharmaceutical retail players, while the commerce ministry has issued policy support for drugstore operators to develop new modes of retail operations. These include professional pharmacies, integrated pharmacies with clinics as well as traditional Chinese medical centers. AliHealth first gained a presence in the drug dispensary sector as early as 2016 when it set up the China Pharmaceutical O2O Pioneer Alliance with 65 chains including Baijiahui Suhe Pharmacy and Tak Sung Tong Medicine. The company also acquired Wu Qian Nian Pharmaceutical in 2016. Editor: William Clegg

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.